Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2015.11.004
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Metastatic Renal Cell Carcinoma: Radiologic Findings and Assessment of Response to Targeted Antiangiogenic Therapy by Using Multidetector CT

Radiographics
MedicineNuclear MedicineRadiologyImaging
2013English

Chromophobe Renal Cell Carcinoma

2012English

Endogenous Retroviral Signatures Predict Immunotherapy Response in Clear Cell Renal Cell Carcinoma

Journal of Clinical Investigation
Medicine
2018English

Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2013English

Proteomic Identification of Interleukin-2 Therapy Response in Metastatic Renal Cell Cancer

Journal of Urology
Urology
2008English

Brain Complete Response to Cabozantinib Prior to Radiation Therapy in Metastatic Renal Cell Carcinoma

Case Reports in Urology
2019English

Predictive Proteomic Signatures for Response of Pancreatic Cancer Patients Receiving Chemotherapy

Clinical Proteomics
Molecular MedicineClinical BiochemistryMolecular Biology
2019English

CXCR2 Inhibition Combined With Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer

PLoS ONE
Multidisciplinary
2015English

Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy